What Happens When You Stop Mounjaro? Weight Regain, Tapering and Maintenance
When you stop Mounjaro, appetite returns within weeks and, without a plan, much of the lost weight tends to come back. In the SURMOUNT-4 trial, people switched to placebo after 36 weeks regained 14% of their body weight over the next year. Stopping is safe; stopping without a maintenance plan is what goes wrong.
ALTRcare Medical Team
Clinical Editorial
When you stop Mounjaro, its effect on appetite wears off over the following weeks, hunger returns to something like before, and without a plan a large part of the lost weight usually comes back. That is not a guess: SURMOUNT-4, a trial designed to test exactly this, measured it. The good news is that stopping is medically safe, there is no withdrawal, and regain is far more manageable when the exit is planned with your doctor rather than done abruptly.
Key takeaways
- In SURMOUNT-4, after 36 weeks on tirzepatide (average loss 20.9%), people switched to placebo regained 14% of body weight over the next year. Those who continued lost a further 5.5%.
- Regain is biology, not failure. Obesity behaves like a long-term condition, and the medicine works while you take it.
- You can stop after 3 months, but at that point most people are still at a low dose and still losing. Stopping early usually means stopping mid-result.
- Options are not all-or-nothing: a planned step-down, a lower maintenance dose, or continued use, decided with your doctor.
- Protein, strength training and a set of habits built while on the medicine are what hold results afterwards.
What SURMOUNT-4 showed
SURMOUNT-4 (published in JAMA, December 2023) enrolled adults with obesity or overweight, without diabetes. Everyone took tirzepatide for 36 weeks, building up to the highest dose they tolerated (10 mg or 15 mg). Over those 36 weeks, average weight loss was 20.9%. Then participants were randomly split: half continued tirzepatide, half were switched to a placebo injection without knowing it, and both groups were followed for another 52 weeks.
By the end, at 88 weeks, the group that stopped was on average 9.9% below their starting weight, compared with 25.3% for the group that continued. Put simply, roughly half of what the stopping group had lost came back within a year. A later analysis of the same trial found that improvements in blood pressure, cholesterol and blood sugar also partly reversed as the weight returned. Results vary by person, and this was an abrupt stop with no taper and no structured maintenance programme.
Why the weight comes back
Tirzepatide quiets hunger signals and slows stomach emptying while it is in your body. It has a half-life of about five days, so within a few weeks of the last dose those effects fade. Meanwhile your body, now lighter, pushes appetite up to defend its old weight. Knowing this in advance is what lets you plan for it.
This matches what we say about all GLP-1 medicines in our GLP-1 maintenance guide: the medicine works while you take it, and the exit plan matters as much as the start.
Can I stop Mounjaro after 3 months?
You can. Nothing dangerous happens when you stop, and you do not need to taper for safety reasons. The question is whether it makes sense. On the usual ladder, month 3 is 7.5 mg (or 5 mg if your doctor holds you there), and most people are still losing weight at that point. In SURMOUNT-1, the average results of 15.0% to 20.9% were measured at 72 weeks, not 12. Stopping at 3 months usually means leaving before the medicine has done most of its work, and then facing regain on top.
Good reasons to stop early do exist: side effects that do not settle, a planned pregnancy, a new medical condition, or cost. If cost is the reason, talk to the doctor before stopping. Staying at a lower effective dose, or switching to generic semaglutide (ALTRcare's semaglutide plan is ₹10,999 for 3 months), may be better than stopping outright. Our Mounjaro results guide shows what a typical timeline looks like.
Tapering vs stopping
SURMOUNT-4 tested an abrupt switch to placebo, not a gradual step-down, so there is no large trial yet proving that tapering prevents regain. In practice, many doctors prefer a planned step-down, reducing the dose over a few months while watching weight and appetite, because it lets you practise your habits with gradually less help and shows early if hunger is coming back too fast.
- Abrupt stop: simplest, but appetite returns over a few weeks with no chance to adjust.
- Planned step-down: dose reduced in steps under supervision, with a check on weight at each step. The evidence is limited, but it gives you and your doctor time to react.
- Lower maintenance dose: some people hold their weight on a dose below the one that got them there. This is a doctor's judgement; trial data on the lowest effective maintenance dose is still emerging.
- Continued use: for people with type 2 diabetes, marked insulin resistance or a large amount of weight still to lose, staying on medication may be the right medical choice, as with BP or thyroid medicine.
Want a plan with the exit built in?
Take the free 2-minute assessment. A senior specialist plans the whole journey with you on a free video call: the dose ladder, the maintenance phase and when stopping makes sense.
The habits that hold results
The months on Mounjaro give you a window when appetite is quiet and eating less is easy. The people who keep weight off use that window to build what still works when the appetite comes back:
- Protein at every meal. Dal, paneer, curd, eggs, soya, chicken. It keeps you full and protects muscle. Our Mounjaro diet plan has a sample Indian day.
- Strength training two to three times a week. Muscle keeps your metabolism higher; see our muscle loss guide.
- A daily walk, especially after meals.
- Weekly weigh-ins after stopping, with an agreed action point (for example, a 2 to 3 kg rise) at which you call the doctor rather than waiting.
- Sleep and stress: short sleep and high stress both push appetite up, and they matter more once the medicine is gone.
Agree the plan before you stop, not after regain starts
Decide with your doctor what dose you will step to, how you will track weight, and what happens if it climbs. That conversation, held in advance, is the single most useful thing you can do.
How ALTRcare handles the long term
Every consultation is with a senior specialist: Dr. Mujeeb Afzal (MD, DM Endocrinology), Dr. (Major) Bhavesh Talera (MD, MRCP (UK), FRCP, internal medicine), Dr. Archana Rathi (diabetologist, ex-Registrar Bombay Hospital, PCOS and women's health) or Dr. Snigdha Sehgal (MD Internal Medicine). The same doctor who starts you plans the maintenance phase with you, and your nutritionist adjusts the diet plan as the dose changes.
The tirzepatide 3-month plan is ₹34,999 (₹11,666 a month) for 2.5 mg, 5 mg and 7.5 mg, with three doctor consultations timed to each dose step, a nutritionist and Indian diet plan, WhatsApp support and cold-chain delivery, GST included. The free online doctor consultation costs nothing to book, and if the doctor thinks medication is not right for you, you are told plainly. No sales team, no repeat calls.
Talk to a doctor about the long game
Book a free 15–20 minute video consultation through the 2-minute assessment, whether you are starting, mid-way, or thinking about stopping.
Mounjaro® is a registered trademark of Eli Lilly and Company. Yurpeak® is marketed in India by Cipla. ALTRcare is not affiliated with either company.
Frequently asked questions
What happens when you stop Mounjaro?
Appetite returns over a few weeks and, without a maintenance plan, much of the lost weight tends to come back. In SURMOUNT-4, people switched to placebo after 36 weeks regained 14% of their body weight over the following year.
Will I regain weight after stopping Mounjaro?
Many people regain some or much of it if they stop abruptly without a plan; in SURMOUNT-4 only 16.6% of those who stopped kept at least 80% of their weight loss. A planned step-down, a maintenance dose and habits built during treatment reduce the risk.
Can I stop Mounjaro after 3 months?
Yes, it is safe to stop, and no taper is needed for safety. But at 3 months most people are still at a low dose and still losing weight, so stopping then usually cuts the result short. Discuss it with your doctor first.
Do I need to take Mounjaro forever?
Not necessarily. Some people step down to a lower maintenance dose, some maintain with habits, and some, especially with diabetes or marked insulin resistance, continue longer term. Your doctor helps you decide.
Is it better to taper Mounjaro or stop suddenly?
There is no large trial yet showing tapering prevents regain, but many doctors prefer a supervised step-down because it gives time to spot returning appetite and adjust. Agree the plan with your doctor before stopping.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed, with no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
